Regarding NAFLD, Jing et al. demonstrated that serum levels of CXCL16 were elevated in NAFLD patients and that CXCL16 was strongly expressed around the steatotic hepatocytes in liver biopsy specimens [55]. The gene discussed is CXCL16; the disease is metabolic dysfunction-associated steatotic liver disease.